Satellite Symposium Addresses the Role of Advanced Multiplex Molecular Testing in Diagnostic Stewardship

October 6, 2024 9:00 AM

Program developed by Medavera, Inc. will take place during IDWeek 2024LOS ANGELES, CA / ACCESSWIRE / October 6, 2024 / With infectious diseases ranking as the third leading cause of death globally and the growing health threat of antimicrobial resistance, multiplex molecular assays are emerging as a powerful new diagnostics tool. During a live satellite symposium held during IDWeek 2024, three global infectious disease experts will be addressing...

Read more

Asentech LLC Wins Gold at 2024 PM360 Trailblazer Awards for Excellence in Digital Innovation

October 6, 2024 12:00 AM

Asentech LLC proudly announces its Gold win at the prestigious 2024 PM360 Trailblazer Awards in the App/Digital Solution category. This recognition solidifies Asentech's position as a leader in digital healthcare solutions, reflecting its unwavering commitment to driving transformative innovations within the life sciences industry.The PM360 Trailblazer Awards honor the most impactful achievements in healthcare marketing, recognizing companies...

Read more

Is Cosmetic Dentistry Affordable?

October 5, 2024 12:00 PM

Cosmetic dentistry refers to voluntary procedures that help improve the smile's aesthetic appearance. As these procedures help create straighter, brighter smiles, patients often also experience a boost in confidence and better oral functionality, like better chewing and speech. With benefits like this, many patients would like cosmetic procedures done, but some may worry they're cost-prohibitive. In this article, we'll explore the most common...

Read more

ClinMedica Delivers Advanced Hair Transplantation and Plastic Surgery With Personalized, Cutting-Edge Care

October 5, 2024 9:00 AM

ISTANBUL, TURKEY / ACCESSWIRE / October 5, 2024 / ClinMedica, a notable medical clinic based in Istanbul, is making strides in the fields of hair transplantation and plastic surgery. The clinic operates under the expertise of Dr. Kokmen Kosher, who specializes in hair transplantation, and Op. Dr. Nüret Özcen, a plastic surgeon known for her comprehensive approach to aesthetic procedures. ClinMedica ClinMedica Hair Transplantation Extraction and...

Read more

Patients for Patient Safety US Celebrates White House Recognition of Project PIVOT and Thanks World Patient Safety Day Scholarship Donors

October 4, 2024 5:00 PM

WASHINGTON, DC / ACCESSWIRE / October 4, 2024 / On September 17, World Patient Safety Day (WPSD), the Biden-Harris Administration announced new actions to improve patient and workforce safety during a White House Healthcare Safety Forum. These actions prominently included the commitment made by Patients for Patient Safety US (PFPS US) to work together with a diverse community of stakeholders to develop Project PIVOT, a year-long patient-led...

Read more

UNOS Applauds Introduction of the Organ Donation Referral Improvement Act

October 4, 2024 2:15 PM

The United Network for Organ Sharing (UNOS) today applauded the introduction of the bipartisan Organ Donation Referral Improvement Act by U.S. Reps. Rob Wittman, Jennifer McClellan, Mariannette Miller-Meeks and Jim Costa.The bipartisan legislation aims to optimize the deceased organ donor referral process by identifying and recommending best practices for software tools used by hospitals and organ procurement organizations. This will help to...

Read more

Ottobock and Kennesaw State University Collaborate for Mobility Clinic, Empowering and Building Community Through and Connection

October 4, 2024 1:00 PM

AUSTIN, TX / ACCESSWIRE / October 4, 2024 / Ottobock, a global leader in prosthetic and orthotic technology, has partnered with Kennesaw State University's Wellstar College of Health and Human Services' Master of Science in Prosthetics and Orthotics (MSPO) program to host a transformative Full Circle Movement mobility clinic on October 12th, 2024. This event, taking place at Kennesaw State University's Fifth Third Stadium, offers a unique...

Read more

Notice of Extraordinary General Meeting in Ascelia Pharma AB

October 4, 2024 10:00 AM

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.MALMÖ, SWEDEN / ACCESSWIRE / October 4, 2024 / Ascelia Pharma (STO:ACE) The shareholders in Ascelia Pharma AB, Reg. No. 556571-8797, are hereby invited to the extraordinary general meeting (Sw. extra bolagsstämma) to be held at the premises of Setterwalls Advokatbyrå AB at Stortorget 23...

Read more

Ascelia Pharma Announces Proposal for Election of Marianne Kock as New Member of the Board of Directors

October 4, 2024 9:45 AM

The Nomination Committee of Ascelia Pharma AB (publ) ("Ascelia Pharma" or the "Company") (Nasdaq Stockholm:ACE) proposes that Marianne Kock is elected as new member of the board of directors at an extraordinary general meeting in the Company to be held on 30 October 2024. The notice of the extraordinary general meeting will be published through a separate press release.With a strong background as an executive in companies in the pharmaceutical...

Read more

Career on Purpose (Episode 1): Merck's Skills-First Program

October 4, 2024 9:40 AM

NORTHAMPTON, MA / ACCESSWIRE / October 4, 2024 / Episode 1 of Career On Purpose, a new podcast series from Merck, features an engaging conversation on the company's transformative "Skills-First" program, which helps attract, develop, advance and retain talented people who don't have four-year degrees.In this episode, Ngozi Motilewa, enterprise HR lead for Merck's Skills-First Diversity Talent Initiative, shares details on the program's origins,...

Read more

Justera Health Announces Debt Settlement Transaction

October 4, 2024 9:35 AM

Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ( " Justera "or the" Company " ) is pleased to announce that it will enter into debt settlement agreement to settle an outstanding debt in the amount of approximately C$355,570 (the " Debt ") owing to a certain non-arm's-length creditor of the Company, by issuing 7,111,400 Units (the " Units ") at a deemed price of C$0.05 per Unit. Each Unit consists of one Common share and one Share Purchase...

Read more

Aero Pump and Resyca Partner to Launch Ultra Soft Nasal Pump Spray, Targeting Precise Nasal Drug Delivery Applications

October 4, 2024 9:00 AM

Now available for licensing, Ultra Soft Nasal Pump Spray leverages innovative spray nozzle chip technology for superior nasal cavity coverage - ideal for nose-to-brain therapies, vaccination, and other advanced multidose nasal applications.ENSCHEDE, NETHERLANDS / ACCESSWIRE / October 4, 2024 / Aero Pump and Resyca are proud to announce their collaboration in the launch of the innovative Ultra Soft Nasal Pump Spray. Available for licensing...

Read more

Better Together: Nasser Orthodontics Will Merge With Cosse & Silmon Orthodontics on October 1, 2024

October 4, 2024 8:00 AM

SHREVEPORT, LA / ACCESSWIRE / October 4, 2024 / Orthodontic patients in Louisiana will soon have a new reason to smile. Dr. Peter H. Nasser and the team at Nasser Orthodontics are merging with Cosse & Silmon Orthodontics to create an even better orthodontic experience for Louisiana families.Dr. Nasser is a seasoned orthodontist with over 30 years of experience, specializing in personalized care for kids, teens, and adults. "Our goal is to treat...

Read more

HTL-Strefa Responds to Growing Calls for Affordable Healthcare With Cost-Effective Diabetes Solutions

October 4, 2024 8:00 AM

Amidst recent news on healthcare pricing, HTL-Strefa, part of the MTD Group, reinforces its commitment to delivering innovative, high-quality pen needles at lower costs, with the Droplet brand rapidly expanding across U.S. marketsWOODSTOCK, GA / ACCESSWIRE / October 4, 2024 / As you may have seen in recent news, there is growing pressure to make healthcare more affordable to patients. Core to our strategy at HTL-Strefa, an MTD company, is a...

Read more

Relief Therapeutics Reports Positive Results from RLF-OD032 Proof-of-Concept Clinical Study for Phenylketonuria

October 4, 2024 1:20 AM

RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today reported positive topline results from its proof-of-concept clinical study evaluating RLF-OD032, an innovative and highly concentrated liquid formulation of sapropterin dihydrochloride, for the treatment of phenylketonuria...

Read more

Healthcare Executive Shamus McGuire Advocates for Increased Funding and Support for Healthcare Startups in New Jersey

October 3, 2024 9:01 PM

Shamus McGuire, a seasoned healthcare executive with over 28 years of experience, is calling for more funding and support for healthcare startups in New Jersey. McGuire, known for his strategic leadership roles at Prime Therapeutics, Magellan Rx Pharmacy, and Cigna Pharmacy Management, believes that bolstering the healthcare startup ecosystem is essential to drive innovation, improve patient care, and strengthen the state's economy. "New...

Read more

MedMira Announces the appointment of Vice President of Commercial Operations

October 3, 2024 7:00 PM

HALIFAX, NS / ACCESSWIRE / October 3, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) today announced the appointment of Nicole Crenshaw as Vice President of Commercial Operations, effective immediately. Ms. Crenshaw's addition strengthens MedMira's leadership team as the company targets significant growth across its commercial portfolio.Ms. Crenshaw brings over 25 years of experience in Clinical Diagnostics, with a background in Business...

Read more

N=1 Collaborative Welcomes Hugh Hempel as Executive Director to Lead the Next Phase of Growth

October 3, 2024 5:07 PM

Industry veteran brings expertise to scale patient access to life-changing individualized therapiesBOSTON, MA / ACCESSWIRE / October 3, 2024 / The N=1 Collaborative (N1C), a non-profit organization representing over 700 researchers, physicians, and scientists dedicated to advancing treatments for rare disease patients, is proud to announce the appointment of Hugh Hempel as its inaugural Executive Director. With a distinguished career in rare...

Read more

1933 Industries to Trade on the Pink Open Market

October 3, 2024 5:00 PM

1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTC Pink:TGIFF), a Nevada-focused cannabis cultivator and producer, announces that its common stock was moved from the OTCQB Market to the OTC Pink Open Market, as it no longer meets the minimum closing bid price standards for continued eligibility on the OTCQB. The Pink Open Market provides brokers with a regulated platform for transparent trading.About 1933 Industries...

Read more

NHI Announces Third Quarter 2024 Earnings Release and Conference Call Dates

October 3, 2024 4:00 PM

National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the third quarter ended September 30, 2024. NHI plans to issue its earnings release after the market closes on Tuesday, November 5, 2024, and will host a conference call on the following day, Wednesday, November 6, 2024, at 11:00 a.m. Eastern Time to discuss the results. The number to call for this interactive teleconference is (888) 506-0062, with...

Read more